Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
Diyuan Xue, Benjamin Moon, Jing Liao, et al.
Science Immunology (2022) Vol. 7, Iss. 67
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Novel strategies exploiting interleukin-12 in cancer immunotherapy
Assunta Cirella, Carlos Luri‐Rey, Claudia Augusta Di Trani, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 82
Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity
Mengrui Liu, Shiqi Hu, Na Yan, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 4, pp. 565-575
Closed Access | Times Cited: 82
Interferon-stimulated neutrophils as a predictor of immunotherapy response
Madeleine Benguigui, Tim J. Cooper, Prajakta Kalkar, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 253-265.e12
Open Access | Times Cited: 55
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan Chen, Linda T. Nieman, Maxwell Spurrell, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 644-658
Open Access | Times Cited: 50
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Treatment strategies for clear cell renal cell carcinoma: Past, present and future
Junwei Yang, Kuansong Wang, Zhichun Yang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
Shufen Xu, Yue Xu, Nicholas C. Solek, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 24
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 42
Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy
Yuhao Jiang, Yanhao Zhang, Chao Liu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 663-675
Closed Access | Times Cited: 12
Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine
Christine M. Minnar, Grace Lui, James L. Gulley, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 9
Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion
Bin Wang, Maoping Tang, Qijing Chen, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15499-15516
Closed Access | Times Cited: 9
T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics
Jian‐Hong Liao, Hong Pan, Guojun Huang, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114086-114086
Open Access | Times Cited: 8
M2 macrophage-targeting peptide-modified liposomes enhance the uptake and antitumor efficacy of liposomal IFN-γ in mice with C26 colon carcinoma
Maryam Kateh Shamshiri, Roghayyeh Vakili‐Ghartavol, Hammed Tanimowo Aiyelabegan, et al.
Cytokine (2025) Vol. 187, pp. 156860-156860
Closed Access | Times Cited: 1
Nanoplatform Self‐Assembly from Small Molecules of Porphyrin Derivatives for NIR‐II Fluorescence Imaging Guided Photothermal‐Immunotherapy
Yanbing Cao, Wei De, Lixia Yang, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 32
Engineering cytokines for cancer immunotherapy: a systematic review
Yong Fu, Renhong Tang, Xiaofeng Zhao
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications
Rong Jiao, Xia Lin, Qian Zhang, et al.
Progress in Materials Science (2023) Vol. 142, pp. 101230-101230
Closed Access | Times Cited: 20
Transforming Cancer-Associated Fibroblast Barrier into Drug Depots to Boost Chemo-Immunotherapy in “Shooting Fish in a Barrel” Pattern
Shijun Yuan, Weiwei Mu, Shujun Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13611-13626
Closed Access | Times Cited: 17
Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects
Yuankui Zhu, Ke Wang, Linghe Yue, et al.
Pharmacological Research (2024) Vol. 203, pp. 107186-107186
Open Access | Times Cited: 7
Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity
Wenqiang Shi, Nan Liu, Zexin Liu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101531-101531
Open Access | Times Cited: 6
Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review)
Yuhang Zhou, Wenjie Han, Yun Feng, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 1
Open Access | Times Cited: 6
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
Qi Wang, Kai Wang, Xiaojing Tan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Nanotechnology Applications in Breast Cancer Immunotherapy
Ruijie Wang, Pramod Kumar, Moataz Reda, et al.
Small (2023)
Closed Access | Times Cited: 13
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice
Matthias Düchs, Ramona F. Kratzer, Pablo Vieyra-Garcia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity
Yusuke Ito, Hitomi Kasuya, Mirei Kataoka, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010005-e010005
Open Access
Page 1 - Next Page

Scroll to top